Aton Pharma

company

About

Aton Pharma is a specialty pharmaceutical company focusing on ophthalmic diseases, orphan conditions, and acute care hospital products.

  • 11 - 50

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$13.70M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

Aton Pharma, Inc. operates as a specialty pharmaceutical company. It focuses on ophthalmic diseases, orphan conditions, and acute care hospital products. The company offers products for metabolic, neurological, and cardiovascular diseases, as well as provides products for under-treated diseases, including dry eye. Its products include timolol maleate ophthalmic gel forming solution for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The company serves patients, caregivers, and healthcare professionals in the United States, the Asia Pacific region, Australia, and internationally. Aton Pharma, Inc. was formerly known as Avatar. The company was founded in 2001 and is based in Lawrenceville, New Jersey. Aton Pharma, Inc. is a former subsidiary of Merck & Co., Inc.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$13.70M
Aton Pharma has raised a total of $13.70M in funding over 2 rounds. Their latest funding was raised on Jan 10, 2003 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 10, 2003 Private Equity(PE) $13.70M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Aton Pharma is funded by 1 investors. Perseus-Soros Biopharmaceutical Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Perseus-Soros Biopharmaceutical Fund Private Equity(PE)